Dynavax Technologies Corporation (DVAX)

$12.91 $0.10 (0.82%) 4:38 PM 12/11/24
NASDAQ | $USD | Drug Manufacturers - Specialty & Generic

Stock Data

  • Market Cap

    $1.69B
  • Day's Range

    $12.85 - $13.01
  • Volume

    1,370,756
  • 52 Week Low / High

    $9.74 - $15.01
  • PE Ratio

    85.67x
  • PEG Ratio

    -
  • Dividend Frequency

    -

DVAX's Dividend
-
Amount
-
Dividend Yield
Nov 30
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
2
Strong Buy
2
Buy
1
Hold
0
Sell
0
Strong Sell
$24.50
Target Price

Company News

  • Oculis Holding AG (OCS) Surges 8.2%: Is This an Indication of Further Gains? — Oct 8th, 2024

    Oculis Holding AG (OCS) shares ended the last trading session 8.2% higher at $14.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.5% gain over the past four weeks. The company is developing...

  • Oculis Holding AG (OCS) Surges 8.2%: Is This an Indication of Further Gains? — Oct 8th, 2024

    Oculis Holding AG (OCS) shares ended the last trading session 8.2% higher at $14.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.5% gain over the past four weeks. The company is developing...

  • Oculis Holding AG (OCS) Surges 8.2%: Is This an Indication of Further Gains? — Oct 8th, 2024

    Oculis Holding AG (OCS) shares ended the last trading session 8.2% higher at $14.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.5% gain over the past four weeks. The company is developing...

  • Oculis Holding AG (OCS) Surges 8.2%: Is This an Indication of Further Gains? — Oct 8th, 2024

    Oculis Holding AG (OCS) shares ended the last trading session 8.2% higher at $14.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.5% gain over the past four weeks. The company is developing...

  • Oculis Holding AG (OCS) Surges 8.2%: Is This an Indication of Further Gains? — Oct 8th, 2024

    Oculis Holding AG (OCS) shares ended the last trading session 8.2% higher at $14.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.5% gain over the past four weeks. The company is developing...

  • Oculis Holding AG (OCS) Surges 8.2%: Is This an Indication of Further Gains? — Oct 8th, 2024

    Oculis Holding AG (OCS) shares ended the last trading session 8.2% higher at $14.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.5% gain over the past four weeks. The company is developing...

  • Oculis Holding AG (OCS) Surges 8.2%: Is This an Indication of Further Gains? — Oct 8th, 2024

    Oculis Holding AG (OCS) shares ended the last trading session 8.2% higher at $14.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.5% gain over the past four weeks. The company is developing...

  • Oculis Holding AG (OCS) Surges 8.2%: Is This an Indication of Further Gains? — Oct 8th, 2024

    Oculis Holding AG (OCS) shares ended the last trading session 8.2% higher at $14.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.5% gain over the past four weeks. The company is developing...

  • Oculis Holding AG (OCS) Surges 8.2%: Is This an Indication of Further Gains? — Oct 8th, 2024

    Oculis Holding AG (OCS) shares ended the last trading session 8.2% higher at $14.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.5% gain over the past four weeks. The company is developing...

Similar Stocks

  • CLDX.US Logo

    CLDX

    Celldex Therapeutics Inc

  • IMCR.US Logo

    IMCR

    Immunocore Holdings Ltd

  • NRIX.US Logo

    NRIX

    Nurix Therapeutics inc

  • VRDN.US Logo

    VRDN

    Viridian Therapeutics Inc

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free